Two years later, she became the first paediatric patient to be offered a form of treatment called CAR-T, in which the body’s ...

The National Pharmaceutical Pricing Authority (NPPA) has sanctioned the ceiling price hike for 11 formulations by 50 per cent ...

Asthma Attack Symptoms . Symptoms of an asthma attack may develop gradually or happen suddenly and can vary from person to ...

In the phase 3b BATURA trial, Airsupra—a pressurized metered-dose inhaler containing albuterol and budesonide—significantly ...

Tired of sniffling and sneezing, or worse, are allergies getting in the way of you living the life you deserve? Whether your ...

Asthma is a chronic respiratory condition that affects many children worldwide, causing inflammation and narrowing of the ...

Depemokimab has already shown its potential as a therapy for severe asthma in two other phase 3 trials – SWIFT-1 and SWIFT-2 ...

The medicines for which the prices have been increased are not very expensive to begin with and are not expected to hit ...

In another Gazzette notification, the drug pricing regulator fixed the retail price of 20 new drugs under the provisions of ...

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that five abstracts have been accepted for e-Poster ...

Full session details can be accessed on the ACAAI website. The poster will be available on the publications page of the Apogee website on October 24.